CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL

Clinical trial NCT06346912 · RECRUITING

Trial details

NCT number: NCT06346912
Sponsor: Zhejiang University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia,B-Cell Non-hodgkin Lymphoma,B Cell

Start date: 2024-05-30
Primary completion: 2027-05-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.